Wang G-Q, Abnet C C, Shen Q, Lewin K J, Sun X-D, Roth M J, Qiao Y-L, Mark S D, Dong Z-W, Taylor P R, Dawsey S M
Cancer Prevention Studies Branch, Center for Cancer Research, National Cancer Institute, 6116 Executive Boulevard, Suite 705, Bethesda, MD 20892-8314, USA.
Gut. 2005 Feb;54(2):187-92. doi: 10.1136/gut.2004.046631.
Oesophageal squamous cell carcinoma (OSCC) has a very poor prognosis, which is largely due to late diagnosis. Successful early detection strategies will require identification of clinically relevant precursor lesions that can be targets for screening and treatment.
To identify the clinically relevant histological precursors of OSCC.
A cohort of 682 endoscoped patients from a high risk rural population in Linxian, China.
Subjects were endoscoped and biopsied at baseline and followed for 13.5 years. We estimated the relative risk of developing OSCC for each of the initial histological diagnoses using Cox proportional hazards regression models.
A total of 114 (16.7%) patients developed OSCC during the follow up period. After adjusting for potential confounding factors, relative risks (95% confidence intervals) for incidence of this tumour, by initial histological diagnosis, were: normal 1.0 (reference), oesophagitis 0.8 (0.2-3.2), basal cell hyperplasia 1.9 (0.8-4.5), mild dysplasia 2.9 (1.6-5.2), moderate dysplasia 9.8 (5.3-18.3), severe dysplasia 28.3 (15.3-52.3), and carcinoma in situ 34.4 (16.6-71.4).
In this study, squamous dysplasia and carcinoma in situ were the only histological lesions associated with a significantly increased risk of developing OSCC within 13.5 years after endoscopy. There was no evidence that oesophagitis predisposed to this tumour. Increasing grades of dysplasia were strongly associated with increasing risk, indicating that the histological grading was clinically meaningful. The follow up experience of severe dysplasia and carcinoma in situ was equivalent, suggesting that this distinction is not clinically relevant. Documenting these precursor lesions of OSCC should assist in the development of effective prevention, early detection, and treatment strategies for this disease.
食管鳞状细胞癌(OSCC)预后很差,这在很大程度上归因于诊断较晚。成功的早期检测策略需要识别出可作为筛查和治疗靶点的临床相关前驱病变。
识别OSCC临床相关的组织学前驱病变。
来自中国林县高危农村人群的682例接受内镜检查的患者队列。
研究对象在基线时接受内镜检查和活检,并随访13.5年。我们使用Cox比例风险回归模型估计每种初始组织学诊断发生OSCC的相对风险。
随访期间共有114例(16.7%)患者发生OSCC。在调整潜在混杂因素后,根据初始组织学诊断,该肿瘤发病的相对风险(95%置信区间)分别为:正常1.0(参照)、食管炎0.8(0.2 - 3.2)、基底细胞增生1.9(0.8 - 4.5)、轻度异型增生2.9(1.6 - 5.2)、中度异型增生9.8(5.3 - 18.3)、重度异型增生28.3(15.3 - 52.3)和原位癌34.4(16.6 - 71.4)。
在本研究中,鳞状上皮异型增生和原位癌是内镜检查后13.5年内与发生OSCC风险显著增加相关的仅有的组织学病变。没有证据表明食管炎易引发该肿瘤。异型增生程度增加与风险增加密切相关,表明组织学分级具有临床意义。重度异型增生和原位癌的随访情况相当,提示这种区分在临床上并无关联。记录这些OSCC的前驱病变应有助于制定针对该疾病的有效预防、早期检测和治疗策略。